The Protection Role of Nano-Doped Zinc Oxide on F2-Isoprostane as Biomarkers of Oxidative Stress in STZ- Induced Diabetic Retinopathy in Male Rats

Oxidative stress (OS) has been suggested as one of basic mechanism behind the development of type 2 diabetes especially diabetic retinopathy (DR). Isoprostanes (IsoPs) are involved in type 2 diabetes and increased in pathological conditions associated with OS. Our present study was designed to prepare Cl: ZnO nano particles (Cl: ZnONPs) and evaluate the effect of ZnCl 2 and Cl: ZnONPs at (5 and 10mg/kg bw) on retinal oxidative stress in STZ-induced diabetic rats. The male albino rats treated with one dose of streptozotocin (60mg/kg bw). The diabetic rats were administrated Zn Cl 2 and Cl: ZnONPs (5 and 10mg/kg bw) orally for 3 days. The results investigated that TEM of Cl: ZnONPs has average particle size 14.5-70nm. Serum insulin and SOD were decreased and serum glucose and IsoPs were increased significantly (P≤0.05) 72h after treatment with STZ (60mg/kg bw) than other groups. A significant decreased (P≤ 0.05) in glucose and F 2 IsoPs levels and significant increase in insulin and SOD levels were detected also in retina in STZ diabetic rats which treated with ZnCl 2 and Cl: ZnONPs (5 and 10mg/kg bw). Cl: ZnONPs (10mg/kg bw) + (60mg/kg bw) gave the best results compared to ZnCl 2 (5 and 10mg/kg bw) + STZ and Cl: ZnONPs (5mg/kg bw) + STZ. In conclusion, Cl: ZnONPs have a highly protective effect against hyperglycemia and diabetic retinopathy oxidative stress, especially at (10mg/kg bw) dosage. Protection Role of Nano-Doped Zinc Oxide on F2-Isoprostane as Biomarkers of Oxidative Stress in STZ- Induced Diabetic Retinopathy in Male Rats. Biomed J Sci


Introduction
Diabetes mellitus is a group of metabolic diseases in which has high blood sugar in person, either because the body does not produce enough insulin, or because cells do not respond to the insulin that is produced [1]. All over the world there are many people suffer from diabetes [2], approximately (25.9%) [3]. Oxidative stress (OS) due to the imbalance between pro-oxidant/antioxidant status results in generation of reactive oxygen species (ROS) and free radicals or impaired antioxidant defense system [4], subsequent modification of biomolecules such as protein, lipids and nucleic acids. Excessive generation of ROS and free radicals have been implicated in a variety of pathological events such as ischemia-reperfusion injury, cardiovascular disease [5] hepatorenal syndrome [6], scleroderma [7], smoking [8], coronary reperfusion injury [9], atherosclerosis [10], diabetes mellitus [11,12] and neurodegenerative disease.
Oxidative stress appears to be an integral and possibly causative part of the pathogenesis of diabetic retinopathy. Compelling evidence has been provided that both insulin-dependent and non-insulin-dependent diabetic patients are under conditions of oxidative stress and that the complications of diabetes mellitus (thereafter indicated as diabetes) could be partially mediated by oxidative stress [13] and that peroxide formation is increased in elevated glucose solutions. [14,15] Oxidative damage of cellular membranes has been suggested as a common mechanism in many bio pathological conditions. It can be measured by either primary or secondary end products of peroxidation. [16] while secondary end products include thiobarbituric reactive substances (TBARS), DOI: 10.26717/BJSTR.2020.30.004995 23636 F2-like products termed F2-isoprostanes (F2-IsoPs). [17,18] Increased levels of F2-IsoPs can be found in the plasma of patients affected with type I and type II diabetes [11,19] and in animal models of diabetes [20] and currently are used as in vivo indicators of lipid peroxidation [11,13,21,22]. Zinc (Zn) is the most abundant trace intracellular element required for several cellular processes, including cell proliferation, reproduction, immune function and defense against free radicals [23]. It plays an important role as an antioxidant, protects cellular components from oxidation, [24]an activator for more than three hundred enzymes in the body [25] and in different metabolic pathways including glucose metabolism.
[26] Also, Zinc promotes hepatic glycogenesis through its actions on the insulin pathways, storage, secretion [27] and thus improves glucose utilization [28]. Due to its fast electron transfer capability, ZnO is a key material for fabrication of bio membranes, and enzymatic detective devices [29]. Many studies have addressed the importance of ZnO as an antioxidant and a therapeutic agent in several free radicals initiating systems [26,30]. Nano-ZnO is a product whose particle diameter is between 1to 100nm. More recently, the study of ZnO nanoparticles is a very active area [31,32].
Umrani, and Paknikar, [33] reported that the antidiabetic effects of ZnONPs through induction of insulin, also, they proved the ability of ZnONPs for controlling of blood glucose in diabetic rats. Soheir et al. [34] investigate the useful effects of high dose of F: ZnO and Cl: ZnO nanoparticles in protection diabetic rats against hyperglycemia and retina against oxidative stress. There is only one study that monitored the effect of Cl: ZnO nanoparticles on diabetic rats, but there is not previous study carried out with Cl: ZnO nanoparticles on the role of iso prostane during diabetic rats. Therefore, this work designed to prepare ZnO nanoparticles doped with chlorine (Cl: ZnOPNs) and reviews the role of ZnCl 2 and Cl: ZnONPs on F2-Iso prostane as biomarkers of oxidative stress in retinal in relation to type II diabetes in rats.

Experimental
The ZnO nanoparticles doped with chlorine was prepared by a chemical solution method from zinc acetate (ZnAc) and oxalic acid.

Characterization
The structure was analyzed by FTIR spectra (FTIRNicolet6700).

Biological Methods
Male albino adult rats (60 animals weighing 130g±5) were obtained from the private market, Helwan, Giza, Egypt, then transported to Animal House of Ophthalmology Research Institute, Giza, Egypt. Rats were housed in individual cages with screen bottoms and fed on basal diet (corn starch 70%, casein 10%, corn seed oil 10%, cellulose 5%, salt mixture 4% and vitamins mixture 1%) for ten days. After equilibration, rats were weighted and divided into six groups (ten animals per each) everyone was assigned to one of the six diet groups (G1: Negative Control (NC), G2: STZ-treated group that injected with a single ip dose of STZ (60mg/kg bw), G3: treated group that received a single dose of STZ (60mg/kg bw)+ single daily oral low dose of ZnCl 2 (5 mg/kg b.w), G4: treated group that received a single dose of STZ (60mg/kg b.w) + single daily low dose of Cl: ZnONPs (5mg/kg b.w), G5: treated group that received a single dose of STZ (60 mg/kg b.w) + single daily oral high dose of ZnCl 2 (10 mg/kg b.w), G6: treated group that received a single dose of STZ (60mg/kg b.w) + single daily high dose of Cl:ZnONPs (10mg/kg bw). Rats were sacrificed at 0, 24, 48, and 72 h after STZ treatment. Before the rats were sacrificed, blood was collected from the orbital sinus and serum was prepared and kept frozen at -20˚C until the time of assay. Each eye was immediately enucleated, the lens was removed, and the retina was gently peeled away from the pigment epithelium and placed in 500 ml ice-chilled 10mmol/l sodium phosphate buffer, pH 8.0.

Measurements of Blood glucose and Insulin
Blood glucose (mg/dL) was estimated by glucose oxidase method using the kit supplied by SPINREACT (Sant Estevade Bas, Girona, Spain) according to, [35] we measured blood glucose in all experimental animals before the beginning of the experimental procedures, after streptozotocin injection. After that, blood glucose was monitored in all experimental animals, and results were obtained at 0, 24, 48 and 72h of the experimental period. Serum insulin was measured using an insulin radio immunoassay kit.

Statistical Analysis.
The results are represented as mean ±SE and statistically analyzed by using one-way ANOVA. Accepted level of significance (P ≤ 0.05). Figure 1 shows the FT-IR at sorption spectrum prepared sample (Cl: ZnONPs). The peak at 470cm -1 is the characteristic distinct stretching vibration of zinc oxide. The broad absorption peak at 3400cm -1 can be attributed to the characteristic absorption of hydroxyls group. These results agree with Soheir et al. [34]. They reported that the undoped ZnO, an absorption peak is observed centered at 372nm (3.33 eV), which is in good agreement with previously reported works of ZnO single crystals and Cl: ZnONPs.   Figure 3 shows the Cl: ZnONPs powder prepared with chlorine doping have average particle size 14.5-70.0nm.  Table 1 Shows the changes of serum glucose levels induced by ZnCl 2 and Cl: ZnONPs in diabetic rats. Experimental groups treated by ZnCl 2 and Cl: ZnONPs (5 and 10mg/kg bw)for 3 days, showed a significant (P≤0.05) decreased in serum glucose levels, it found to be (138.022,116.094 mg/dl), (117.962,102.964 mg/dl) at 5 and 10 mg/kg bw), respectively after 72h. Additionally, Cl: ZnONPs (10mg/ Kg bw)+STZ (60 mg/kg bw) treated group results were close to normal values that showed in NC group. This showed a great antidiabetic activity of zinc oxide nanoparticles, as zinc has been elucidated to be a potent metal that improves glucose utilization and metabolism through its potent influence on enhancement of hepatic glycogenesis through actions on the insulin signaling pathway [34].

Biochemical Markers
Alkaladi et al. [31] showed a great reduction in blood glucose level in diabetic groups treated with ZnONPs, SNPs and insulin. However, ZnONPs induce more reduction than SNP. Rehal et al. [38] reported that at 30, 60, 90 and 120 min, the plasma glucose levels in the STZinduced rats were treated with Vildagliptin, ZnONPs, and various combinations of the two, groups, for 7 weeks showed significant improvements compared to the diabetic group (group II). The maximum improvement in the reduced plasma glucose levels was observed in the rats treated with the combination therapy (Vildagliptin plus 10mg/kg/d ZnONPs, group IIIh) compared to diabetic group and the other treated groups [38]. Also, a great reduction in blood glucose level in diabetic groups treated with low and high dose of F: ZnONPs and Cl: ZnONPs, it found to be 119.03, 117.10, 108.97 and 103.97mg/dl after 72 h, respectively [34].  uIU/ml) ( Table 2). The serum insulin levels were significantly decreased in the diabetic group compared to the control group [38].
This results may be due to zinc could enhance the glucose stimulated insulin secretion from rat isolated pancreatic islets [40] Umrani and Paknikar [33] demonstrated that ZnONPs did not possess the risk of hypoglycemia in living organisms so it can act as an insulin secretor/due to accumulation of zinc in the secretory vesicle of B cells using transporter 8 [40]. Zinc transporters are also identified in adipose tissues and liver [34,41]. Treatment with ZnONPs. induced a significant increase in the serum insulin levels compared to the diabetic group (NC) [38]. The groups administration high dose of F: ZnONPs and Cl: ZnONPs gave a best result (326.40 and 367.80 pg/ ml), respectively, compared to PC (175.40 pg/ml) [34]. ZnONPs and SNP could increase serum insulin level in diabetic groups, it found (79.4% and 3%), respectively if compared with diabetic groups treated with insulin (97.3%). It appeared that ZnONPs also induced more insulin secretion if compared to the effect of SNPs [31]. ZON treatment showed a trend towards a dose-dependent increase in nonfasted serum insulin levels (35% increase at 10 mg/kg dose).
However, no significant effects were seen on fasted serum insulin levels after ZON treatment, indicating no risk of hypoglycemia [33]. The best results were observed in diabetic rats treated with ZnONPs in a dose of (10mg/kg b.w) [42].  (Table 3). Increase in plasma level of total F 2 -IsoPs in type 2 diabetic nephropatic patients (P ≤0.01) with respect to controls [43]. Increased F2-IsoPs synthesis during diabetes appears to be responsible in part for the increase in renal TGF-β,α well-known mediator of diabetic nephropathy [6].

Conclusion
Based on our results, we can conclude that ZnCl 2 and Cl: ZnONPs lead to activation of insulin mechanism of action and induction its synthesis. Cl: ZnONPs + STZ incresead SOD and decreased F 2-IsoPs activates significantly (P ≤ 0.05). Furthermore, the results elucidated the beneficial effects of high dose of Cl: ZNONPs gave the best results protection retinal against oxidative stress and controlling hyperglycemia.